Effects at Xuezhikang capsule on cardiac function in chronic heart failure and C-reactive protein
YE Chun-xiang
WANG Ying-zhi
SHI Zhan
Abstract：Objective To investigate the effect of Xuezhikang capsule on chronic heart failure (CHF) and C-reactive protein (CRP). Methods Forty-eight patients were randomly divided into two groups. Control group (22 cases) had angiotensin-converting enzyme inhibitor β-blockers, diuretics and digitalis preparations treatment. Based on the same treatment of the control group, patients in Xuezhikang group (26 cases) were given extra Xuezhi-kang capsule 0.6g, twice a day. Echocardiography was taken to the two groups, and CRP level was tested by en-zyme-linked immunoabserbent assay. Results After treatment, the total effective rate of Xuezhikang group (88. 5%) was higher than that of control group (68.2%). CRP in Xuezhikang group(2.87±1.34) mg/L was decreased after treatment (P < 0.05). After treatment, the heart function of both group were significantly improved, especially in Xuezhikang group. Conclusion Xuezhikang capsule improves the heart function and reduces serum CRP level in chronic heart failure patients.
Keywords：Chronic heart failureXuezhikang capsuleC-reactive protein
Publication Date：2009-01-01
Online Publishing Date：2026-09-14(First online date of this platform, not the publication date of the document)
Pages：2( 858-859 )